Catalysts

PRODUCTS

  • Isolated Antibody Drug Conjugates ADCs GettyImages-1438509824
    Antibody-Drug Conjugates

    Antibody drug conjugates (ADCs) are the emerging class of anti-cancer therapeutic drugs. ADCs combine an antibody capable of recognizing cancer cells and cytotoxic small-molecule drugs via cleavable or non-cleavable linkers, thereby transforming the 3-unit combination into a targeted therapeutic drug for cancer treatment. In recent years, ADCs have rapidly developed and there are not only more than 14 approved drugs on the market but also many investigational drugs undergoing clinical trials. Furthermore, ADCs have shown potential for treating various diseases beyond cancer, such as Autoimmune disorders, Infectious diseases, Inflammatory conditions and so on.  

  • check computer for vitals-GettyImages-1446748436
    How iMednet Addresses Key Industry Challenges

    In today’s complex clinical research landscape, sponsors and CROs face numerous challenges that can impact study timelines, costs, and data quality. The iMednet platform offers innovative solutions to address these critical issues.

  • VSX3746
    X-Band 1.5 kW GaN High Power Solid State Power Amplifier: VSX3746

    The VSX3746 is a high-power X-band solid-state power amplifier (SSPA) that operates within the 9.0–10.0 GHz frequency range and delivers a nominal peak RF output of 1.5 kW, with a minimum of 1.2 kW.

  • Eppendorf - Bioblu
    BioBLU® Single-Use Bioreactor Product Line

    BioBLU Single-Use Bioreactors combine the advantages of single-use technology with the trusted performance of stirred-tank design. Different variants are suitable for cell culture and microbial fermentation in R&D and clinical and commercial manufacturing. BioBLU Single-Use Bioreactors are compatible Eppendorf bioprocess controllers.

  • Sensors Unlimited - SU1024-LDH2-Product-Image
    SWIR Linescan Camera @ 92 kHz: 1024LDH2

    The SUI 1024-LDH2 is a second-generation, high-speed 1024-pixel linescan InGaAs camera that increases the A-line rate to 91,911 lines per second (lps).

WHITE PAPERS AND CASE STUDIES

NEWS

ABOUT

 

Catalysts

Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy.  For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.

Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.

All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present.  When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.

Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst.  Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.

Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature.  Applications of this technology include oil and petrochemical industries.